The Idolbuster

JANUARY 15, 2013

Chapter 9: Paint Your Environment: Part 5. I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. Bad management? The rest of the company scrambled to fill the $10M revenue hole. Sounds like it.

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

Harvard Business Review

FEBRUARY 22, 2017

In previous work we found that cybersecurity ranked as a top political issue for corporate directors, trailing only the economy and the regulatory environment. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., chemicals, metals & mining, paper & forest products).

Telecommunications 8

Telecommunications Health Care Contingency Plans Biotechnology 8

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. While recruitment errors happen, the performance evaluation highlights those shortcomings and gives the manager and the employee a chance to correct the situation.

Company 8

Company Pharmaceuticals Biotechnology Short-term 8

Harvard Business Review

SEPTEMBER 21, 2018

Innovation ranks fifth, after more-conventional concerns such as attracting and retaining top talent and the regulatory environment. Still, it’s telling that board members rate their boards better on risk management than on innovation. To better understand the competitive landscape, directors suggested engaging with management.

Innovation 8

Innovation Short-term Telecommunications Long-term 8

Harvard Business Review

DECEMBER 30, 2011

What if, instead of trying to fix people, we assumed that they were already full of potential and created an environment that promoted their long-term well-being? In other words, what if cultivating a successful inner life was front and center on the leadership agenda? I remember sitting there and saying, 'There's got to be a another way.'".

Development 15

Development Biotechnology CIO Short-term 15

Harvard Business Review

FEBRUARY 3, 2015

Your relationships are also the best way to change with your environment and industry, even if your formal role or assignment has not changed. This article will show you how to reinvent your network, by managing these three critical dimensions. It’s what you rely on to win over the skeptics.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. Corporate directors identified talent management as their single greatest strategic challenge. We know that organizations commit enormous resources and effort to talent management, so why aren''t they doing a better job? Not rising costs.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. To appreciate how significant simply identifying an ethical dilemma is, consider the choice of Rajat Gupta, the former managing director of McKinsey & Company, to call a billionaire hedge fund trader after a Goldman Sachs board meeting.

Ethics 8

Ethics Training Biotechnology Morale 8

Harvard Business Review

JULY 22, 2015

” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. Of course it was natural for a boss to have mixed feelings about seeing a valued employee move on, but David was more than Mark’s manager: He was his mentor.

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

AUGUST 23, 2016

Directors are also consistent in their views of the key challenges to achieving their companies’ strategic objectives: attracting and retaining top talent, the regulatory environment, and domestic competitive threats top the list for directors from both parties. banking & financial services, insurance, real estate); Healthcare (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8